COMP and ovarian carcinoma: To evaluate the potential protective role of recombinant COMP against apoptosis, through binding to the cell surface, in ovarian cancer cells, we conducted an Annexin V-Zombie aqua dye apoptosis assay, with cisplatin serving as the apoptosis inducer (Additional file 1: Fig. S2F).